Julie Plée Selected Research

Peptide Hydrolases (Proteases)

12/2015	Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome.
12/2014	Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie Plée Research Topics

Disease

7	Bullous Pemphigoid (Pemphigoid) 01/2018 - 12/2014
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 03/2017
2	Blister (Bulla) 12/2015 - 12/2014
1	Eosinophilia 11/2020
1	Pruritus (Itching) 11/2020
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 01/2018
1	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 01/2018
1	Inflammation (Inflammations) 12/2014
1	Skin Diseases (Skin Disease) 12/2014

Drug/Important Bio-Agent (IBA)

4	AutoantibodiesIBA 11/2020 - 12/2014
3	Interleukin-17 (Interleukin 17)IBA 03/2017 - 12/2014
3	Interleukin-23 (Interleukin 23)IBA 03/2017 - 12/2014
2	Peptide Hydrolases (Proteases)FDA Link 12/2015 - 12/2014
1	Collagen Type VIIIBA 01/2018
1	AntibodiesIBA 01/2018
1	glucocorticoid receptor betaIBA 12/2017
1	Chemokine CXCL10IBA 03/2017
1	Biomarkers (Surrogate Marker)IBA 03/2017
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 03/2017
1	Eosinophil Cationic ProteinIBA 01/2017
1	CytokinesIBA 12/2015
1	Interleukin-22 (IL-22)IBA 12/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2014
1	Interleukin-6 (Interleukin 6)IBA 12/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2014
1	Leukocyte Elastase (Neutrophil Elastase)IBA 12/2014

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2015